Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Veterinary Raw Materials > NVP BGJ398 phosphate for Sale > Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price
Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price buy - large image1
Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price buy - image1
Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price buy - image2
Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price buy - image3
Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price buy - image4

Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price

7 Inquiries

Unit Price: Get Latest Price
CAS No.:

1310746-10-1

Grade:

Pharmaceutical Grade

Content:

99.5%

Port:

Hangzhou

Brand:

HyperChem

Packaging:

1kg/Bag

Price valid (until):

2024-11-24

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Name

    Infigratinib phosphate

    CAS number

    1310746-10-1

    Synonym

    Parecoxib sodium; SC-69124A; SC 69124A; SC69124A; Dynastat

    Description

    Parecoxib, also known as SC-69124A and Dynastat, is a cyclooxygenase-2 inhibitor used for the short-term treatment of postoperative pain in adults. Parecoxib is a water-soluble and injectable prodrug of valdecoxib. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). Unlike ketorolac, parecoxib has no effect on platelet function and therefore does not promote bleeding during or after surgery. In addition, ketorolac has a much higher gastrointestinal toxicity profile compared to most other nonsteroidal antiinflammatory drugs (NSAIDs) including ibuprofen and naprosyn.

    Structure

        Shop Infigratinib phosphate CAS 1310746-10-1 Powder Fast Shipping Best Price-Detailed Image 1

    Molecular Formula

    C19H19N2NaO4S

    Molecular Weight

    394.42 g/mol

    Appearance

    White powder

    Quality Standard

    99%

    Shipping Condition

    Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition

    Dry, dark and at 2~8 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

    Shelf Life

    >2 years if stored properly

    Sample package

    Aluminium foil bag, Bottle

    Commercial package

    Aluminium Tin

    Origin

    China

    Infigratinib phosphate More Info

    Parecoxib sodium is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to the class of selective COX-2 inhibitors. It is primarily used for its analgesic and anti-inflammatory properties, specifically to manage postoperative pain.

    Chemical Composition

    Parecoxib sodium is the sodium salt of parecoxib, with a chemical formula of C16H16N2O3S·Na. It is a prodrug, meaning that it is converted in the body to its active form, which is the COX-2 inhibitor.

    Mechanism of Action

    Parecoxib sodium selectively inhibits cyclooxygenase-2 (COX-2), an enzyme involved in the synthesis of prostaglandins, which are mediators of inflammation and pain. By inhibiting COX-2, parecoxib reduces the production of pro-inflammatory prostaglandins, leading to decreased pain and inflammation without significantly affecting cyclooxygenase-1 (COX-1), which is important for gastrointestinal protection and maintaining platelet function.

    Therapeutic Uses

    Parecoxib sodium is primarily indicated for:

    1. Postoperative Pain Management: It is often used to manage acute pain following surgical procedures, both in the hospital setting and after outpatient surgeries.
    2. Pain Relief in Other Conditions: It may also be utilized for other types of acute pain conditions, as directed by healthcare providers.

    Dosage and Administration

    Parecoxib sodium is typically administered intravenously or intramuscularly. The dosage and duration of treatment depend on the patient's specific condition, the severity of pain, and individual response to the medication. It is generally administered shortly before or after surgery to provide early pain relief.

    Side Effects

    Common side effects associated with parecoxib sodium may include:

    • Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain
    • Headache
    • Dizziness
    • Injection site reactions (if administered via injection)

    Serious side effects, though rare, can include:

    • Cardiovascular events (e.g., heart attack or stroke), particularly with prolonged use
    • Gastrointestinal bleeding, given that all NSAIDs carry this risk, albeit parecoxib is designed to be safer for the gastrointestinal tract compared to traditional NSAIDs
    • Renal issues, particularly in patients with pre-existing kidney condition

    Contraindications and Precautions

    Parecoxib sodium is contraindicated in certain situations, including:

    • Known hypersensitivity to parecoxib, any of its components, or other sulfonamide drugs.
    • Active gastrointestinal bleeding or a history of gastric ulcers.
    • Severe renal or liver impairment.
    • Patients who have had recent coronary artery bypass graft surgery.

    Caution is advised in patients with a history of cardiovascular disease due to the potential risks associated with COX-2 inhibitors.

    Drug Interactions

    Parecoxib sodium can interact with several medications, including:

    • Other NSAIDs, which can increase the risk of gastrointestinal complications.
    • Anticoagulants (e.g., warfarin), which may elevate the risk of bleeding.
    • Diuretics and antihypertensive medications, as COX-2 inhibitors can potentially reduce their effectiveness.

    Patients should inform their healthcare provider about all medications they are taking to identify potential interactions and ensure safe administration.

    Conclusion

    Parecoxib sodium is a selective COX-2 inhibitor that provides effective pain relief, particularly in the postoperative setting. While it has advantages in its targeted mechanism of action and reduced gastrointestinal risks compared to traditional NSAIDs, it should be used under the guidance of a healthcare professional. Patients are encouraged to adhere to prescribed dosages and report any side effects or concerns to their healthcare provider to ensure safe and effective treatment.


    Product Image

    Shop High Quality Oxytocin CAS 50-56-6-Detailed Image 2

    Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 3



    Basic Info
    Product Name:

    NVP BGJ398 phosphate

    Other Name:

    INFIGRATINIB PHOSPHATE;BGJ-398 PHOSPHATE;BGJ-398 PHOSPHATE; BGJ 398 PHOSPHATE; NVP BGJ398 PHOSPHATE;BGJ 398 phosphate;BGJ-398 phosphate;NVP BGJ398 phosphate;NVP-BGJ398 (phosphate);N'-(2,6-Dichloro-3,5-dimethoxyphenyl)-N-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-N-methylurea phosphate (1:1);BGJ-398,NVP-BGJ398,Infigratinib

    CAS No.:

    1310746-10-1

    Molecular Formula:

    C26H34Cl2N7O7P

    InChIKeys:

    GUQNHCGYHLSITB-UHFFFAOYSA-N

    Molecular Weight:

    658.47

    Color/Form:

    White to gray

    Characteristics
    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Company Certificates
    • Hangzhou Hyper Chemicals LimitedCertification Report by Bureau Veritas Certification Report by Bureau Veritas
    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Inquiry History
    7 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    NVP BGJ398 Phosphate

    1 KG Jul 15, 2026
    United States

    NVP BGJ398 phosphate

    3 G Jul 15, 2026
    United States

    NVP-BGJ398 phosphate

    18 G Jul 14, 2026
    United States

    NVP BGJ398 phosphate

    4 G Mar 11, 2026
    United States

    NVP BGJ398 Phosphate / Infigratinib Phosphate

    50 G Oct 16, 2026
    United States

    Infigratinib

    9 G Jul 18, 2026
    United States

    Infigratinib phosphate powder

    6 G Jun 9, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.